+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Perioperative Pain Management"

From
Postoperative Pain - Epidemiology Forecast - 2032 - Product Thumbnail Image

Postoperative Pain - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 162 Pages
  • Global
From
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
Surgery of the Hip. Edition No. 2 - Product Thumbnail Image

Surgery of the Hip. Edition No. 2

  • Book
  • November 2019
Basics of Anesthesia: First South Asia Edition - Product Thumbnail Image

Basics of Anesthesia: First South Asia Edition

  • Book
  • September 2018
  • Asia Pacific
  • 13 Results (Page 1 of 1)
Loading Indicator

The Perioperative Pain Management market is a subset of the Analgesics market, which focuses on the management of pain during and after surgical procedures. Analgesics are drugs used to reduce or eliminate pain, and are typically administered before, during, and after surgery. Common analgesics used in perioperative pain management include opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and local anesthetics. Opioids are used to provide short-term pain relief, while NSAIDs are used to reduce inflammation and local anesthetics are used to numb the area around the surgical site. In addition to analgesics, other treatments used in perioperative pain management include nerve blocks, epidural injections, and transcutaneous electrical nerve stimulation (TENS). Nerve blocks are used to block pain signals from reaching the brain, while epidural injections are used to reduce inflammation and provide long-term pain relief. TENS is a non-invasive treatment that uses electrical stimulation to reduce pain. Companies in the Perioperative Pain Management market include Pfizer, Merck, Johnson & Johnson, Novartis, and Sanofi. Show Less Read more